Kazuhisa Tsukamoto
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.
Journal: The New England journal of medicine
Published: March 25, 2026
A Catalog of the Pathogenic Variants in ABCG5 and ABCG8 and Clinical Features in Sitosterolemia.
Journal: Journal of atherosclerosis and thrombosis
Published: February 11, 2026
Non-Achievement of Low-Density Lipoprotein Cholesterol Management Goals: Implications on High-Risk Cardiovascular Disease Patients Within the Japan Atherosclerosis Society 2022 Guideline Recommendations.
Journal: Circulation reports
Published: November 18, 2025
Roxadustat Activates Thyroid Hormone Receptors α and β at Clinically Relevant Concentrations.
Journal: Cureus
Published: August 10, 2025
Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass.
Journal: Endocrine journal
Published: February 12, 2024
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
Journal: Journal of atherosclerosis and thrombosis
Published: December 20, 2023
C-reactive protein modulates lipid mediators in a pro-inflammatory direction.
Journal: Journal of inflammation (London, England)
Published: October 12, 2023
Managing hypertriglyceridemia for cardiovascular disease prevention: Lessons from the PROMINENT trial.
Journal: European journal of clinical investigation
Published: October 10, 2023
Understanding impacts of COVID-19 restrictions on glycemic control for patients with diabetes in Japan.
Journal: Journal of diabetes and metabolic disorders
Published: June 19, 2023
Apolipoprotein M/sphingosine 1-phosphate protects against diabetic nephropathy.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: September 22, 2022
Last Updated: 09/26/2026